Logo image of DVA

DAVITA INC (DVA) Stock Fundamental Analysis

NYSE:DVA - US23918K1088 - Common Stock

138.68 USD
+1.35 (+0.98%)
Last: 8/26/2025, 4:25:39 PM
138.68 USD
0 (0%)
After Hours: 8/26/2025, 4:25:39 PM
Fundamental Rating

5

DVA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While DVA has a great profitability rating, there are some minor concerns on its financial health. DVA may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year DVA was profitable.
DVA had a positive operating cash flow in the past year.
DVA had positive earnings in each of the past 5 years.
Each year in the past 5 years DVA had a positive operating cash flow.
DVA Yearly Net Income VS EBIT VS OCF VS FCFDVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

DVA's Return On Assets of 4.78% is fine compared to the rest of the industry. DVA outperforms 76.24% of its industry peers.
DVA's Return On Invested Capital of 11.06% is amongst the best of the industry. DVA outperforms 85.15% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DVA is in line with the industry average of 9.14%.
The last Return On Invested Capital (11.06%) for DVA is above the 3 year average (9.26%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.78%
ROE N/A
ROIC 11.06%
ROA(3y)4.27%
ROA(5y)4.62%
ROE(3y)305.73%
ROE(5y)220.5%
ROIC(3y)9.26%
ROIC(5y)9.4%
DVA Yearly ROA, ROE, ROICDVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200 400 600

1.3 Margins

The Profit Margin of DVA (6.35%) is better than 83.17% of its industry peers.
In the last couple of years the Profit Margin of DVA has remained more or less at the same level.
The Operating Margin of DVA (15.01%) is better than 89.11% of its industry peers.
DVA's Operating Margin has been stable in the last couple of years.
DVA has a Gross Margin of 32.54%. This is in the better half of the industry: DVA outperforms 60.40% of its industry peers.
DVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.01%
PM (TTM) 6.35%
GM 32.54%
OM growth 3Y0.04%
OM growth 5Y-0.21%
PM growth 3Y-4.61%
PM growth 5Y0.51%
GM growth 3Y1.6%
GM growth 5Y1.53%
DVA Yearly Profit, Operating, Gross MarginsDVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DVA is creating some value.
The number of shares outstanding for DVA has been reduced compared to 1 year ago.
DVA has less shares outstanding than it did 5 years ago.
DVA has a worse debt/assets ratio than last year.
DVA Yearly Shares OutstandingDVA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DVA Yearly Total Debt VS Total AssetsDVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

DVA has an Altman-Z score of 1.69. This is a bad value and indicates that DVA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DVA (1.69) is comparable to the rest of the industry.
DVA has a debt to FCF ratio of 7.97. This is a slightly negative value and a sign of low solvency as DVA would need 7.97 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 7.97, DVA is doing good in the industry, outperforming 60.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.97
Altman-Z 1.69
ROIC/WACC1.4
WACC7.92%
DVA Yearly LT Debt VS Equity VS FCFDVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

DVA has a Current Ratio of 1.39. This is a normal value and indicates that DVA is financially healthy and should not expect problems in meeting its short term obligations.
DVA's Current ratio of 1.39 is in line compared to the rest of the industry. DVA outperforms 44.55% of its industry peers.
DVA has a Quick Ratio of 1.34. This is a normal value and indicates that DVA is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.34, DVA perfoms like the industry average, outperforming 50.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.34
DVA Yearly Current Assets VS Current LiabilitesDVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

5

3. Growth

3.1 Past

DVA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.67%.
The Earnings Per Share has been growing by 11.47% on average over the past years. This is quite good.
Looking at the last year, DVA shows a small growth in Revenue. The Revenue has grown by 5.09% in the last year.
Measured over the past years, DVA shows a small growth in Revenue. The Revenue has been growing by 2.39% on average per year.
EPS 1Y (TTM)7.67%
EPS 3Y1.41%
EPS 5Y11.47%
EPS Q2Q%18%
Revenue 1Y (TTM)5.09%
Revenue growth 3Y3.32%
Revenue growth 5Y2.39%
Sales Q2Q%6.05%

3.2 Future

The Earnings Per Share is expected to grow by 13.60% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.87% on average over the next years.
EPS Next Y15.52%
EPS Next 2Y16.46%
EPS Next 3Y15.51%
EPS Next 5Y13.6%
Revenue Next Year5.35%
Revenue Next 2Y4.44%
Revenue Next 3Y4.21%
Revenue Next 5Y4.87%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DVA Yearly Revenue VS EstimatesDVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
DVA Yearly EPS VS EstimatesDVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

DVA is valuated correctly with a Price/Earnings ratio of 14.31.
Based on the Price/Earnings ratio, DVA is valued cheaply inside the industry as 83.17% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of DVA to the average of the S&P500 Index (27.08), we can say DVA is valued slightly cheaper.
DVA is valuated reasonably with a Price/Forward Earnings ratio of 10.76.
Based on the Price/Forward Earnings ratio, DVA is valued cheaper than 83.17% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.67, DVA is valued rather cheaply.
Industry RankSector Rank
PE 14.31
Fwd PE 10.76
DVA Price Earnings VS Forward Price EarningsDVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

DVA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DVA is cheaper than 82.18% of the companies in the same industry.
90.10% of the companies in the same industry are more expensive than DVA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.7
EV/EBITDA 7.18
DVA Per share dataDVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 -100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DVA has a very decent profitability rating, which may justify a higher PE ratio.
DVA's earnings are expected to grow with 15.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.92
PEG (5Y)1.25
EPS Next 2Y16.46%
EPS Next 3Y15.51%

More info and screens

0

5. Dividend

5.1 Amount

DVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DAVITA INC

NYSE:DVA (8/26/2025, 4:25:39 PM)

After market: 138.68 0 (0%)

138.68

+1.35 (+0.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners48.16%
Inst Owner Change-1.1%
Ins Owners4.39%
Ins Owner Change1.24%
Market Cap9.92B
Analysts52.94
Price Target156.61 (12.93%)
Short Float %16.04%
Short Ratio7.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.92%
Min EPS beat(2)1.67%
Max EPS beat(2)4.17%
EPS beat(4)3
Avg EPS beat(4)0.27%
Min EPS beat(4)-9.07%
Max EPS beat(4)4.29%
EPS beat(8)6
Avg EPS beat(8)5.39%
EPS beat(12)8
Avg EPS beat(12)-0.8%
EPS beat(16)11
Avg EPS beat(16)-0.02%
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.48%
Max Revenue beat(2)-0.43%
Revenue beat(4)0
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-0.5%
Max Revenue beat(4)-0.01%
Revenue beat(8)4
Avg Revenue beat(8)0.63%
Revenue beat(12)6
Avg Revenue beat(12)0.2%
Revenue beat(16)7
Avg Revenue beat(16)-0.18%
PT rev (1m)-4.36%
PT rev (3m)-7.86%
EPS NQ rev (1m)-1.42%
EPS NQ rev (3m)-1.42%
EPS NY rev (1m)1.24%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)-0.52%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 14.31
Fwd PE 10.76
P/S 0.75
P/FCF 7.7
P/OCF 5.32
P/B N/A
P/tB N/A
EV/EBITDA 7.18
EPS(TTM)9.69
EY6.99%
EPS(NY)12.88
Fwd EY9.29%
FCF(TTM)18.02
FCFY12.99%
OCF(TTM)26.05
OCFY18.78%
SpS184.07
BVpS-5.17
TBVpS-112.55
PEG (NY)0.92
PEG (5Y)1.25
Profitability
Industry RankSector Rank
ROA 4.78%
ROE N/A
ROCE 13.57%
ROIC 11.06%
ROICexc 11.65%
ROICexgc 26.22%
OM 15.01%
PM (TTM) 6.35%
GM 32.54%
FCFM 9.79%
ROA(3y)4.27%
ROA(5y)4.62%
ROE(3y)305.73%
ROE(5y)220.5%
ROIC(3y)9.26%
ROIC(5y)9.4%
ROICexc(3y)9.63%
ROICexc(5y)9.74%
ROICexgc(3y)20.96%
ROICexgc(5y)20.57%
ROCE(3y)11.35%
ROCE(5y)11.54%
ROICexcg growth 3Y9.54%
ROICexcg growth 5Y5.46%
ROICexc growth 3Y5.31%
ROICexc growth 5Y2.72%
OM growth 3Y0.04%
OM growth 5Y-0.21%
PM growth 3Y-4.61%
PM growth 5Y0.51%
GM growth 3Y1.6%
GM growth 5Y1.53%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.97
Debt/EBITDA 3.75
Cap/Depr 80.59%
Cap/Sales 4.36%
Interest Coverage 250
Cash Conversion 69.28%
Profit Quality 154.04%
Current Ratio 1.39
Quick Ratio 1.34
Altman-Z 1.69
F-Score6
WACC7.92%
ROIC/WACC1.4
Cap/Depr(3y)78.43%
Cap/Depr(5y)87.31%
Cap/Sales(3y)4.74%
Cap/Sales(5y)5.11%
Profit Quality(3y)181.3%
Profit Quality(5y)168.85%
High Growth Momentum
Growth
EPS 1Y (TTM)7.67%
EPS 3Y1.41%
EPS 5Y11.47%
EPS Q2Q%18%
EPS Next Y15.52%
EPS Next 2Y16.46%
EPS Next 3Y15.51%
EPS Next 5Y13.6%
Revenue 1Y (TTM)5.09%
Revenue growth 3Y3.32%
Revenue growth 5Y2.39%
Sales Q2Q%6.05%
Revenue Next Year5.35%
Revenue Next 2Y4.44%
Revenue Next 3Y4.21%
Revenue Next 5Y4.87%
EBIT growth 1Y7.24%
EBIT growth 3Y3.37%
EBIT growth 5Y2.18%
EBIT Next Year43.26%
EBIT Next 3Y16.17%
EBIT Next 5Y11.9%
FCF growth 1Y-5.06%
FCF growth 3Y4.39%
FCF growth 5Y-3.25%
OCF growth 1Y-5.32%
OCF growth 3Y1.55%
OCF growth 5Y-4.13%